BRIEF published on 06/06/2025 at 15:12, 1 year 3 months ago Intrasense étend ses solutions d'IA à l'imagerie oncologique Imagerie IA Intrasens Myrian® DUOnco™ Solutions En Oncologie
BRIEF published on 06/06/2025 at 15:12, 1 year 3 months ago Intrasense Expands AI Solutions in Oncological Imaging Intrasense AI Imaging Oncology Solutions Myrian® DUOnco™
PRESS RELEASE published on 06/06/2025 at 15:07, 1 year 3 months ago Activity Update: structured offering of AI Solutions in oncological imaging and initial successful deployments Intrasense provides structured AI solutions for oncological imaging, incl. Myrian®, DUOnco™, and Liflow®. Successful deployments & collaborations enhance patient care AI Solutions Medical Imaging Collaborations Intrasense Oncological Imaging
BRIEF published on 05/23/2025 at 19:22, 1 year 3 months ago Intrasense annonce un changement au sein de son conseil d'administration Conseil D'administration Imagerie Médicale L'IA Dans Le Secteur De La Santé Steven F. Tolle Intrasens
BRIEF published on 05/23/2025 at 19:22, 1 year 3 months ago Intrasense Announces Board of Directors Change Board Of Directors Medical Imaging AI In Healthcare Intrasense Steven F. Tolle
PRESS RELEASE published on 05/23/2025 at 19:17, 1 year 3 months ago Annule et remplace : Change in the Composition of the Intrasense Board of Directors Intrasense announces a change in its Board of Directors with the resignation of Mrs. Michèle Lesieur and co-opting Mr. Steven F. Tolle. Mr. Tolle brings extensive healthcare experience Board Of Directors Resignation Healthcare Experience Intrasense Steven F. Tolle
BRIEF published on 09/09/2024 at 17:56, 2 years ago Intrasense announces its participation in the 2024 Francophone Radiology Days Innovation Synergies Radiology Intrasense JFR 2024
BRIEF published on 09/09/2024 at 17:56, 2 years ago Intrasense annonce sa participation aux Journées Francophones de Radiologie 2024 Innovation Synergies Radiologie Intrasense JFR 2024
PRESS RELEASE published on 09/09/2024 at 17:51, 2 years ago Intrasense annonce sa participation aux Journées Francophones de Radiologie 2024 Découvrez les nouvelles innovations présentées aux JFR 2024 et les synergies avec Guerbet. Intrasense et la radiologie de demain en lumière ! Innovation Guerbet Radiologie Intrasense JFR 2024
BRIEF published on 07/25/2024 at 17:58, 2 years 1 month ago Intrasense announces its 2024 half-year turnover Software Solutions Reorganization Turnover Intrasense Geopolitics
Published on 09/12/2026 at 02:35, 11 hours 24 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 59 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 54 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 34 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 59 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 28 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 44 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 48 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 14 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 43 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
